BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
暂无分享,去创建一个
M. Bergo | C. Kanduri | T. Mondal | C. Jahangir | Xiufeng Xu | M. Kashif | P. Lindahl | V. Sayin | C. Wiel | Dorian V Ziegler | Mohamed X Ibrahim | Tanushree Ghosh | Haidong Yao | Kristell Le Gal | Clotilde Wiel
[1] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[2] S. Fendt,et al. Metabolic Hallmarks of Metastasis Formation. , 2018, Trends in cell biology.
[3] Donna D. Zhang,et al. NRF2 and the Hallmarks of Cancer. , 2018, Cancer cell.
[4] Matthew E. Ritchie,et al. Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment. , 2018, Cell metabolism.
[5] Hu Li,et al. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming. , 2018, The international journal of biochemistry & cell biology.
[6] Neel S Madhukar,et al. A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product. , 2017, Cell metabolism.
[7] M. V. Vander Heiden,et al. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer , 2017, eLife.
[8] Francisco J. Sánchez-Rivera,et al. Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis , 2017, Nature Medicine.
[9] Ash A. Alizadeh,et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. , 2017, Cancer discovery.
[10] D. Tuveson,et al. ROS in Cancer: The Burning Question. , 2017, Trends in molecular medicine.
[11] Angela N. Brooks,et al. High-throughput Phenotyping of Lung Cancer Somatic Mutations. , 2016, Cancer cell.
[12] Neville E Sanjana,et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening , 2016, Nature Protocols.
[13] Osiris Martinez-Guzman,et al. Heme dynamics and trafficking factors revealed by genetically encoded fluorescent heme sensors , 2016, Proceedings of the National Academy of Sciences.
[14] Xiaocui Wang,et al. NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis , 2016, Science Translational Medicine.
[15] Bjorn Baselet,et al. Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway , 2016, Cellular and Molecular Life Sciences.
[16] J. Locasale,et al. The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.
[17] M. Bergo,et al. Antioxidants can increase melanoma metastasis in mice , 2015, Science Translational Medicine.
[18] R. Deberardinis,et al. Oxidative stress inhibits distant metastasis by human melanoma cells , 2015, Nature.
[19] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[20] K. Pienta,et al. Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells , 2014, Oncotarget.
[21] P. Schumacker,et al. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? , 2014, Nature Reviews Cancer.
[22] Francisco J. Sánchez-Rivera,et al. Rapid modeling of cooperating genetic events in cancer through somatic genome editing , 2014, Nature.
[23] Paul Theodor Pyl,et al. HTSeq – A Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[24] A. Berns,et al. Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma , 2014, Proceedings of the National Academy of Sciences.
[25] D. Bernard,et al. Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence , 2014, Cell Death and Disease.
[26] E. Larsson,et al. Antioxidants Accelerate Lung Cancer Progression in Mice , 2014, Science Translational Medicine.
[27] T. Mak,et al. Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.
[28] Paul D. Smith,et al. Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer , 2013, Clinical Cancer Research.
[29] P. Carmeliet,et al. Role of PFKFB3-Driven Glycolysis in Vessel Sprouting , 2013, Cell.
[30] Y. Okada,et al. HMGA2 is a driver of tumor metastasis. , 2013, Cancer research.
[31] A. Berns,et al. Mouse models for lung cancer , 2013, Molecular oncology.
[32] S. Kung,et al. Transcriptional Network Analysis Identifies BACH1 as a Master Regulator of Breast Cancer Bone Metastasis , 2012, The Journal of Biological Chemistry.
[33] H. Aburatani,et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.
[34] Koichi Kobayashi,et al. Evaluation of unbound free heme in plant cells by differential acetone extraction. , 2012, Plant & cell physiology.
[35] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[36] T. Dick,et al. Measuring E(GSH) and H2O2 with roGFP2-based redox probes. , 2011, Free radical biology & medicine.
[37] Hemant Ishwaran,et al. Signalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancer , 2011, The EMBO journal.
[38] T. Copetti,et al. Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review , 2011, Front. Pharmacol..
[39] T. Finkel,et al. Signal transduction by reactive oxygen species , 2011, The Journal of cell biology.
[40] Scott E. Kern,et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.
[41] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[42] Derek Y. Chiang,et al. Suppression of Lung Adenocarcinoma Progression by Nkx2-1 , 2011, Nature.
[43] Masayuki Yamamoto,et al. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution , 2011, Genes to cells : devoted to molecular & cellular mechanisms.
[44] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[45] M. McMahon,et al. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. , 2010, Antioxidants & redox signaling.
[46] W. Wheaton,et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.
[47] M. Soares,et al. Mechanisms of cell protection by heme oxygenase-1. , 2010, Annual review of pharmacology and toxicology.
[48] M. Gutscher,et al. Proximity-based Protein Thiol Oxidation by H2O2-scavenging Peroxidases*♦ , 2009, The Journal of Biological Chemistry.
[49] T. Jacks,et al. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.
[50] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[51] J. Mackey,et al. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer , 2008, British Journal of Cancer.
[52] Kazuhiro Iwai,et al. Heme Induces Ubiquitination and Degradation of the Transcription Factor Bach1 , 2007, Molecular and Cellular Biology.
[53] Eric S. Lander,et al. Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.
[54] M. Mota,et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria , 2007, Nature Medicine.
[55] J. Herman,et al. Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer , 2006, PLoS medicine.
[56] T. Jacks,et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. , 2005, Cancer research.
[57] Yusuke Nakamura,et al. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. , 2005, Cancer research.
[58] Patricia Soteropoulos,et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. , 2004, Cancer genetics and cytogenetics.
[59] Hiroshi Suzuki,et al. Heme regulates gene expression by triggering Crm1‐dependent nuclear export of Bach1 , 2004, The EMBO journal.
[60] M. Brand,et al. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[61] A. Berns,et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. , 2003, Cancer cell.
[62] Thomas D Pollard,et al. Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.
[63] H. Varmus,et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.
[64] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[65] S. Linn,et al. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene , 2001, Oncogene.
[66] O. Dalesio,et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. , 2000, Journal of the National Cancer Institute.
[67] A. Berns,et al. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. , 2000, Genes & development.
[68] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[69] J. Crowley,et al. The Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2011 .
[70] Keara M. Lane,et al. Mouse models of human non-small-cell lung cancer: raising the bar. , 2005, Cold Spring Harbor symposia on quantitative biology.
[71] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.